Also known as Evista
Raloxifene (marketed as Evista by Eli Lilly and Company) is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women.Source: Wikipedia
Estimated Total Cost: $104.79 for an average of 28 days supply
Patients are most commonly prescribed raloxifene to treat bone disorder, osteoporosis, menopause, and atrophic vaginitis.
Patients taking raloxifene most commonly experience side effects like vaginal bleeding, pain or soreness of breast, and pain.
|Pain or soreness of breast|
|Leg cramps or spasms|
|Cramps and spasms|
|Urinary tract infection|